Amkay Products P/B Ratio
Current P/B Ratio
2.04
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model
Amkay Products (AMKAY) P/B ratio is 2.04 (Moderate), book value per share ₹26.67 vs Healthcare average P/B of -0.32 — High - Premium to book value, growth expectations or asset-light model. View Amkay Products 52-week for the annual high/low range and current price position.
Current Valuation Metrics
P/B Ratio
2.04
Current Price
₹
Book Value/Share
₹26.67
Exchange
None
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹24 Cr
Share Capital
₹9 Cr
Reserves & Surplus
₹15 Cr
Outstanding Shares
9,000,000
Book Value per Share
₹26.67
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.32
Sector Median
0.6
Sector Rank
#11 of 50
Sector Percentile
22.0%
AMKAY P/B Ratio — Valuation Insights & Book Value Analysis
Amkay Products price-to-book ratio interpretation, valuation status and historical context — current P/B 2.04 (Moderate). Review AMKAY earnings valuation to evaluate earnings-based valuation against sector peers.
- Trading at premium to sector average PB of -0.32
AMKAY vs Healthcare Peers — P/B Ratio Comparison
Amkay Products P/B 2.04 vs Healthcare average -0.32, median 0.6 — range -17.45–1.11.
Sector Average
-0.32
Sector Median
0.6
Lowest P/B
-17.45
Highest P/B
1.11
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |